Obermatt
See Similar Stocks →

Apex Biotechnology

TAI:1733 · TW0001733004
Health Care Equipment & SuppliesX-Small

360

72
Medium confidence — indicative
Profit price18
Owner Earnings Yield92
Dividend Yield1
Price/Sales52
EV / Gross Profit41
Price/Book51
Return on Capital87
Cash Return on Capital90
Return on Equity88
EBIT Margin81
Gross Profitability27
Cash Conversion45
Accruals38
Owner Earnings Margin85
Sales growth19
Profit Growth61
Long-Term EPS Growth34
Owner Earnings Growth67
Reinvestment22
Price momentum40
Debt load81
Refinancing64
Debt Payback100
Liquidity65
Analyst ratings15
Expectations trend50
Market mood3
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Apex Biotechnology generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryTaiwan
IndustryHealth Care Equipment & Supplies
SizeX-Small
TypePublic Company
ExchangeTWSE
Founded1997
Employees3
Websiteapexbio.com.tw
ISINTW0001733004
Last UpdateApr 2, 2026
Index & Theme
Health DiagnosticsHematologyBiomedical EngineeringDetectors, Sensors and MemsDiabetesSensors

Description

Analysis

Middle-of-the-road

Apex Biotechnology Corp. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is attractive. You pay 13.0× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone.

The trajectory is moderate and the balance sheet is sturdy. The company scores 16/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
19
2023202420252026

All-time high

96

Jan 2024

All-time low

19

Jun 2026

Average rank

48

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
52
60
59
74
Price/Earnings
65
20
39
56
Price/Book
51
40
45
64
Dividend Yield
1
89
97
99
Value (overall)
42
45
66
77

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Apex Biotechnology with its peers
SD Biosensor
KSC:137310
15
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Japan Lifeline
TYO:7575
86
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Ansell
ASX:ANN
80
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Weltrend Semiconductor
TAI:2436
93
CountryTaiwan
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →
Global Mixed-Mode Technology
TAI:8081
89
CountryTaiwan
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →
Chenbro Micom
TAI:8210
77
CountryTaiwan
IndustryTechnology Hardware, Storage & Peripherals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →